Clopidogrel: The dispute, Sanofi versus Sandoz

In 2009-2010, Sanofi initiated a patent dispute against two manufacturers who sold generic clopidogrel and aspirin—both of which were no longer protected by patent—in a single so-called “combo-box” containing blisters separately housing clopidogrel and aspirin pills.